Skip to content

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.4B+168%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$727.2M-10.1%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$158.33M-247%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$3.64M-80.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$166.56M+1.8%
Biogen logo
BiogenBIIB
$319.5M+32.8%

Segments

By segment

See full
Therapeutics Segment-$128.45M+3.4%

Other financials

Income statement

See full
Revenue-
Operating income-$137.4M+5.6%
EPS (diluted)-$0.69+11.5%

Balance sheet

See full
Cash & equivalents$390.7M+551%
Total debt$40.0M-22.3%
Total equity$926.1M-17.5%
Total assets$1.3B-0.4%

Cash flow

See full
Operating cash flow-$131.2M+0.2%
CapEx$2.5M-51.4%
Free cash flow-$133.7M+2.1%

Valuation

See full
Market cap$3.93B+54.2%

Profitability

See full
Operating margin-37,938%-37,986pp
Net margin-33,121.9%-33,159pp
FCF margin-31,736.3%-31,830pp

Returns & leverage

See full
Return on equity-49.6%+34.2pp
Debt / equity0.0×
Current ratio9.3×-0.3×

Where this comes from

Reported directly by Denali Therapeutics Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Denali Therapeutics Inc.'s net income?
Denali Therapeutics Inc. (DNLI) reported net income of -$128.45M in Q1 2026.
How has Denali Therapeutics Inc.'s net income changed year-over-year?
Denali Therapeutics Inc.'s net income increased by 3.4% year-over-year, from -$132.97M to -$128.45M.
What is the long-term trend for Denali Therapeutics Inc.'s net income?
Over 4 years (2021 to 2025), Denali Therapeutics Inc.'s net income has grown at a 15.2% compound annual growth rate (CAGR), from -$290.58M to -$512.54M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.